Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mifepristone | 55245 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | mifepristone | 55245 | drug-path |
| Long-term potentiation | R-HSA-9620244 | map04720 | mifepristone | 55245 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | mifepristone | 55245 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | mifepristone | 55245 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | mifepristone | 55245 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mifepristone | 55245 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | mifepristone | 55245 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | mifepristone | 55245 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | mepyramine | 4992 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | mepyramine | 4992 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | mepyramine | 4992 | drug-path |
| Chemokine signaling pathway | R-HSA-168638 | map04062 | mepyramine | 4992 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | mepyramine | 4992 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | mepyramine | 4992 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | mepyramine | 4992 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | mepyramine | 4992 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | mepyramine | 4992 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | mepyramine | 4992 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | desipramine | 2995 | drug-path |